This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,491.97 firm fixed-price delivery order contract is for the supply of LUMAKRAS 320 MG TABLET 90S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $13,491.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ03N, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,121.56 Firm Fixed Price delivery order is for the supply of LUMAKRAS 320 MG TABLET 90S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,446.16, is for the delivery of LAZCLUZE 240 MG TABLET 30S, a medical product, and has an ultimate completion date of April 7, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with a set-aside designation....
This is a $35,725.38 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of LUNSUMIO 30 MG/30 ML VIAL, a specialty medication, with a performance period through October 31, 2024. The contract has no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a $1,121.94 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is not set aside and has an ultimate completion date of April 16, 2024. Amerisourcebergen, as a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, is fulfilling this order through its Corporate Office division. The company holds an Indefinite Delivery Contract (IDC)...
This is a $47,738.70 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 7, 2025 and is not designated with a set-aside. Amerisourcebergen is the prime contractor and holds a large $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a $29,049.06 delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medical product "LYBALVI 15-10 MG TABLET UU 30S" and has a firm fixed price. The contract has a completion date of March 21, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order valued at $12,446.16, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of LAZCLUZE 240 MG TABLET 30S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 11, 2025 and is a firm fixed-price arrangement. This award is part of a larger Indefinite Delivery...
This is a $18,791.24 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of pharmaceutical products and medical supplies, with an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceuticals and medical products to the U.S. federal government, particularly the Department of Defense (DoD) and...